The improvement and progress of different kinds of cancer are directed by the aberrant activation of a number of key regulatory signaling proteins such as receptor tyrosine kinases (RTKs), platelet-derived growth factor receptors (PDGFRs), vascular endothelial growth factor receptor (VEGFR), and epidermal growth factor receptor (EGFR). This evidence concerns the gene EGFR and cancer.